GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bal Pharma BALPHARMA.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

83.18

+2.00%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Bal Pharma — daily BSE:BALPHARMA End of day BSE listing — our prices are the NSE line

Why two exchanges. Bal Pharma trades on both NSE and BSE. TradingView's free charts don't carry NSE, so the chart shows the BSE listing. The ticker and close we quote are the NSE line.

Market value
₹1.32bn
Last close × shares
Volume
5.5k
Shares, 9 Nov 2026
Price to earnings
21.2
Dividend yield
1.42%

About Bal Pharma

Its shares trade on NSE under the ticker BALPHARMA.NS. It has been listed since 1 February 1995. In the fiscal year to 31 March 2026, it reported revenue of ₹3.12bn and net income of ₹62.8m. At that date it held total assets of ₹3.76bn and shareholders' equity of ₹822.3m.

Bal Pharma Ltd. is a holding company, which engages in the research, development, and commercialization of pharmaceutical products. The company is headquartered in Bangalore, Karnataka. The firm is engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients (API). The company is specialized in bulk actives, prescription drugs, generics and pharma intermediates. Its focused therapeutic areas are anti-diabetes, anti-histamine, anti-inflammatory, acne treatment, gastroenterology, cardiology, and dermatology. The company offers a range of APIs, which includes antihistamine, platelet inhibitor, anti-diabetic, anti-convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, and acne treatment. Its finished formulation products cover dosage forms, such as tablets, capsules, syrups, suspensions, IV infusions, ophthalmic, creams and ointments. The firm offers a range of natural medicine, which includes ANARSHA, ASHWAMED, AYURFINE, AYURFINE FORTE, AYURSULIN, IMMUWIN, LIPIVED, MENOLEAP CAPSULES, MENOLEAP SYRUP, PROLIFE, and BALPRO SYRUP.

Figures and description from our data supplier, not checked against the company's own report.

More about Bal Pharma →

Latest on Bal Pharma

Our reporting

We have not reported on Bal Pharma yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Bal Pharma's ticker?

Bal Pharma trades as BALPHARMA.NS on NSE, under ISIN INE083D01012.

What was Bal Pharma's last closing price?

83.18 on 9 Nov 2026. The figure is in INR and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.